The results of the randomized, double-blind, placebo-controlled cross-over study demonstrated that GanedenBC30 supports digestive (increased healthy bacteria in the gut) and immune health (improved immune markers) in a healthy senior population.
Senior author of the study, Glenn Gibson, professor of Food Microbial Sciences at the University of Reading and president and founding member of the International Scientific Association for Probiotics and Prebiotics said: “When you are younger, you have a healthier balance of good and bad bacteria. As people age this balance shifts, and often the bad bacteria in the gut increases. In addition, people begin to experience more gastro-intestinal (GI) issues, along with changes in immune function as the majority of your immune cells are in the gut.”
“This study has helped us gain a better understanding of how age affects the gut and to further establish that GanedenBC30 can help support GI and immune health,” said David Keller, vice president of scientific operations, Ganeden Biotech.
For more information: ganedenbiotech.com, www.rb.com